Currently viewing: Creating value for our stakeholders / Next: Statement of value added
Our success and sustainability depend on our positive relationships with, and support of, our key stakeholders. It is essential for us to engage, understand and be responsive to their needs and interests whilst also delivering value to them, in the short, medium and long term.
Material matters key:
1 COVID-19
2 Business disruptions due to social unrest and shortages of critical supplies
3 Labour relations and
employee retention
4 Healthcare funders and the cost of care
5 Specialised skills shortage
6 Quality of care standards
7 Portfolio performance
8 Government relationships
9 Increased regulations
10 Cyber-security and data protection
Stakeholder value creation
Positive
Stable
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
>95% patient satisfaction in AMG
Excellent clinical quality outcomes
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
R7.2 billion in salaries paid (2020: R6.7 billion)
R158 million spent on training (2020: R224 million)
645 nurses trained (2020: 855)
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
Access to our world-class facilities and advanced medical equipment
Bursaries and training to facilitate upskilling
Through our partnership model, we enable doctors and specialists to provide excellent care to patients
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
Business model to deliver high-quality, cost-effective care
Our differentiated service offering
Designated service provider (DSP) network deals in southern Africa and innovative pricing models
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
Our community health projects help uplift the communities in which we operate
Key imaging services partner to public sector internationally
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
Constructive dialogue and relationship with regulatory bodies has contributed in us being able to employ radiographers in SA
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
R35 billion market capitalisation
33.6% increase in share price (1 October 2020 to 30 September 2021)
25 cps final dividend payment (2020: zero)
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
R6.1 billion spent on procurement of supplies, equipment and drugs
R625 million spent on COVID-19-related protective equipment since the beginning of the pandemic
Stakeholder relationship with Life Healthcare
THE VALUE WE CREATE
Uplifting communities through our investment in CSI programmes, focusing on education and healthcare